An MVP is a Critical Bridge to Scaling New Technology. The journey for a successful Digital Transformation initiative follows a five-step approach.
In March 2020, the Pharmaceuticals industry faced one of its most public-facing and time-pressing challenges to date: develop, manufacture, and distribute a vaccine for COVID-19 globally as quickly and safely as possible. While sheer human perseverance played a pivotal role in driving the notable speed to market for the vaccine, this approach is not sustainable nor practical for commercial drug products. Digital methods and tools should be leveraged to achieve similar results in a sustainable, efficient, and profitable way. Pharmaceutical manufacturers now face the need to confront these challenges head-on and embrace connectivity across the value chain, starting with laying the digital foundation for innovation in the form of Digital Knowledge Management and Pharma 4.0.
Based on Kalypso’s experience helping our clients build brand new smart factories and transform traditional plants, here are 12 lessons learned for others undertaking the journey.
In the past 30 years, 3D printing (3DP) technology has gained traction for rapid prototyping and industrial tooling. But just because something can be additively manufactured, should it? Here are some things to consider.